心筋細胞特異の長いノンコーディングRNAは,心臓におけるトリアジン遺伝子の代替スプライシングを調節する
PubMedで要約を見る
まとめ
この要約は機械生成です。新しい長いノンコーディングRNAであるTrdn-asは,トリアジンのスプライシングを調節することにより,心臓の機能を維持するために不可欠です. 欠乏するとカルシウムの処理が妨げられ,心臓病における不律症のリスクが増加します.
科学分野
- 心臓病科
- 分子生物学
- 遺伝学
背景
- 異常なカルシウム (Ca2+) ホメオスタシスは心不律と心不全に関連しています.
- トライアジンタンパク質のアイソフォームは,心筋細胞のCa2+処理に不可欠であり,Trisk32レベルに影響する突然変異は心臓機能障害を引き起こす.
- 心臓におけるトリアジンイソフォームの組成を制御するメカニズムはよく理解されていません.
研究 の 目的
- 心臓機能とトライアジン遺伝子スプライシングの調整における,心筋細胞特異の長いノンコーディングRNA,Trdn-asの役割を調査する.
- Trdn-asがトリアジンレベルと心筋細胞のカルシウム処理に影響を与える分子メカニズムを解明する.
主な方法
- トライアディン発現の分析 人間の心臓のエキスプラントと Trdn-as ノックアウトマウスモデル
- ECGとカテキオラミンの挑戦を用いた心臓機能と不動脈形成の評価
- カーディオミオサイトにおけるCa2+トランジントの測定
- 生物化学,RNAシーケンシング,分子救済アッセイが採用されました.
主要な成果
- Trdn- as ノックアウトはマウスの心臓のトリアジンを減少させ,Ca2+の処理を阻害し,不律症への感受性を高めました.
- 心臓のトリアジン濃度の正常化により,ノックアウト心筋細胞のCa2+処理が回復した.
- Trdn- asは,心筋細胞核のスプライシング因子と相互作用し,トリアジン前駆体mRNAへの誘導を促進する.
結論
- Trdn-asは,トリアジン遺伝子の代替スプライシングを通じて心臓機能を調節し,ロングノンコーディングRNA制御のための新しいメカニズムを表しています.
- Trdn-asまたは代替スプライシング経路をターゲットにすることで,心臓病に対する潜在的な治療戦略が提供されます.
関連する概念動画
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...

